Uracz W, Pituch-Noworolska A, Popiela T, Zembala M
Immunobiology. 1982 Dec;163(5):450-9. doi: 10.1016/S0171-2985(82)80059-4.
The ability of human monocytes from normal donors and gastric-cancer patients to form rosettes with "O" Rh+(D) human erythrocytes coated with hyperimmune IgG anti-D antibody (EAhu) and to kill the same target in antibody-dependent cellular cytotoxicity (ADCC) were assessed. Trypsin pretreatment of normal monocytes decreased their ability to form rosettes with EAhu complexes, but their ADCC activity was unaffected. The Fc receptor (FcR) expression and ADCC activity of monocytes of cancer patients were elevated, and trypsin-treatment led to their further increase. The elevated values were related to the presence of the tumour. These results may suggest that human monocytes possess trypsin-sensitive and trypsin-resistant Fc receptors. The trypsin-resistant FcR seems to be involved in ADCC phenomenon and to be preferentially expressed on monocytes of some cancer patients.
评估了来自正常供体和胃癌患者的人单核细胞与包被有超免疫IgG抗-D抗体(EAhu)的“O”型Rh +(D)人红细胞形成玫瑰花结以及在抗体依赖性细胞毒性(ADCC)中杀伤相同靶标的能力。用胰蛋白酶预处理正常单核细胞会降低其与EAhu复合物形成玫瑰花结的能力,但它们的ADCC活性不受影响。癌症患者单核细胞的Fc受体(FcR)表达和ADCC活性升高,胰蛋白酶处理导致其进一步增加。升高的值与肿瘤的存在有关。这些结果可能表明人单核细胞具有对胰蛋白酶敏感和抗胰蛋白酶的Fc受体。抗胰蛋白酶的FcR似乎参与了ADCC现象,并且在一些癌症患者的单核细胞上优先表达。